Goa-based Molbio Diagnostics Limited, backed by Temasek and Motilal Oswal Private Equity, has filed draft papers with SEBI for an initial public offering. The issue comprises a fresh equity issue of up to ₹200 crore and an offer-for-sale of up to 1.25 crore shares by existing investors. Proceeds will fund a new R&D Centre and Centre of Excellence, strengthen manufacturing units in Goa and Visakhapatnam, and support general corporate needs. Founded in 2000, Molbio is a leader in point-of-care molecular diagnostics with its flagship Truenat® platform. In FY25, the company reported revenues of ₹1,020 crore, a 22% year-on-year growth, with ₹138.5 crore profit after tax.